The pandemic continues to have a polarising effect on the development of paediatric consumer health, in line with the behaviour of various adult categories. 2021 is predicted to see a reversal of fortunes for paediatric ibuprofen which had suffered significant declines the previous year due to misinformation in the media regarding the negative impact of taking this drug for consumers who have contracted the virus; these were quickly refuted by various health organisations, but they nevertheless...

Euromonitor International’s Paediatric Consumer Health in Poland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments , Paediatric Analgesics , Paediatric Cough, Cold and Allergy Remedies , Paediatric Dermatologicals , Paediatric Digestive Remedies , Paediatric Vitamins and Dietary Supplements .

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.